Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Idaho Sen. Brandon Shippy proposes bill to ban mRNA vaccines until 2035 by incorrectly categorizing them as gene therapy, ...

Meet the woman leading vaccine innovation in Senegal to fight Rift Valley fever and empower Africa’s next generation of ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Pennsylvania State Senator Doug Mastriano (R-Franklin/Adams) announced he is introducing a bill that would ensure the state’s food remains free from unauthorized vaccines or ...

In those studies, people vaccinated with the mRNA shot generated antibodies that in lab tests effectively blocked the norovirus protein in human gut cells; those given a placebo vaccine did not ...